These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12191810)

  • 1. Enhanced antidepressant effect of sigma(1) (sigma(1)) receptor agonists in beta(25-35)-amyloid peptide-treated mice.
    Urani A; Romieu P; Roman FJ; Maurice T
    Behav Brain Res; 2002 Aug; 134(1-2):239-47. PubMed ID: 12191810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antidepressant efficacy of sigma1 receptor agonists in rats after chronic intracerebroventricular infusion of beta-amyloid-(1-40) protein.
    Urani A; Romieu P; Roman FJ; Yamada K; Noda Y; Kamei H; Manh Tran H; Nagai T; Nabeshima T; Maurice T
    Eur J Pharmacol; 2004 Feb; 486(2):151-61. PubMed ID: 14975704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antidepressant-like effect induced by the sigma(1) (sigma(1)) receptor agonist igmesine involves modulation of intracellular calcium mobilization.
    Urani A; Romieu P; Portales-Casamar E; Roman FJ; Maurice T
    Psychopharmacology (Berl); 2002 Aug; 163(1):26-35. PubMed ID: 12185397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism.
    Maurice T; Su TP; Privat A
    Neuroscience; 1998 Mar; 83(2):413-28. PubMed ID: 9460750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related expression of sigma1 receptors and antidepressant efficacy of a selective agonist in the senescence-accelerated (SAM) mouse.
    Phan VL; Miyamoto Y; Nabeshima T; Maurice T
    J Neurosci Res; 2005 Feb; 79(4):561-72. PubMed ID: 15635598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test.
    Urani A; Roman FJ; Phan VL; Su TP; Maurice T
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1269-79. PubMed ID: 11504830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interaction with the sigma1 (σ1)-receptor in the acute behavioral effects of antidepressants.
    Villard V; Meunier J; Chevallier N; Maurice T
    J Pharmacol Sci; 2011; 115(3):279-92. PubMed ID: 21427517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain differences in sigma(1) receptor-mediated behaviours are related to neurosteroid levels.
    Phan VL; Urani A; Romieu P; Maurice T
    Eur J Neurosci; 2002 May; 15(9):1523-34. PubMed ID: 12028363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural phenotyping of knockout mice for the sigma-1 (σ₁) chaperone protein revealed gender-related anxiety, depressive-like and memory alterations.
    Chevallier N; Keller E; Maurice T
    J Psychopharmacol; 2011 Jul; 25(7):960-75. PubMed ID: 21555330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats.
    Rex A; Schickert R; Fink H
    Pharmacol Biochem Behav; 2004 Feb; 77(2):303-7. PubMed ID: 14751458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant.
    Akunne HC; Zoski KT; Whetzel SZ; Cordon JJ; Brandon RM; Roman F; Pugsley TA
    Neuropharmacology; 2001 Jul; 41(1):138-49. PubMed ID: 11445194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of sigma agonists on the age-related learning impairment in the senescence-accelerated mouse (SAM).
    Maurice T; Roman FJ; Su TP; Privat A
    Brain Res; 1996 Sep; 733(2):219-30. PubMed ID: 8891305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats.
    Skuza G; Rogóz Z
    J Physiol Pharmacol; 2006 Jun; 57(2):217-29. PubMed ID: 16845227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments.
    Maurice T
    Behav Brain Res; 2016 Jan; 296():270-278. PubMed ID: 26386305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desipramine improves depression-like behavior and working memory by up-regulating p-CREB in Alzheimer's disease associated mice.
    Wang DD; Li J; Yu LP; Wu MN; Sun LN; Qi JS
    J Integr Neurosci; 2016 Jun; 15(2):247-60. PubMed ID: 27338163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.
    Meunier J; Ieni J; Maurice T
    Br J Pharmacol; 2006 Dec; 149(8):998-1012. PubMed ID: 17057756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant effects of creatine on amyloid β
    Rosa JM; Pazini FL; Cunha MP; Colla ARS; Manosso LM; Mancini G; Souza ACG; de Bem AF; Prediger RD; Rodrigues ALS
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():270-278. PubMed ID: 29753049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the antidepressants desipramine and fluvoxamine on latency to immobility and duration of immobility in the forced swim test in adult male C57BL/6J mice.
    Koek W; Sandoval TL; Daws LC
    Behav Pharmacol; 2018 Aug; 29(5):453-456. PubMed ID: 29200003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid toxicity is enhanced after pharmacological or genetic invalidation of the σ
    Maurice T; Strehaiano M; Duhr F; Chevallier N
    Behav Brain Res; 2018 Feb; 339():1-10. PubMed ID: 29129596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding.
    Sugimoto Y; Kajiwara Y; Hirano K; Yamada S; Tagawa N; Kobayashi Y; Hotta Y; Yamada J
    Eur J Pharmacol; 2008 Sep; 592(1-3):116-22. PubMed ID: 18655786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.